Analysts think HSDT stock price could increase by 274%
Jun 14, 2024, 6:28 AM
-3.67%
What does HSDT do
Helius Medical Technologies Inc, a neurotech company based in Newtown, Pennsylvania, focuses on developing non-implantable medical devices like the Portable Neuromodulation Stimulator (PoNS) for treating neurological deficits. Founded in 2014, the company's PoNS device, used in conjunction with physical therapy, assists in treating gait and balance issues in adults over 22 by prescription.
3 analysts think HSDT stock price will increase by 274.31%. The current median analyst target is $4.08 compared to a current stock price of $1.09. The lowest analysts target is $4.04 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
